Sarepta Therapeutics is a commercial stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuro-muscular diseases. Sarepta is working to rapidly advance its exon-skipping platform for the development of treatments for Duchenne muscular dystrophy. To learn more about Sarepta, please visit www.sarepta.com